Tofacitinib Citrate
Ndinaya
Tofacitinib Citrate, nke a makwaara dị ka Xeljanz, bụ ọgwụ iji gwọọ ọrịa ogbu na nkwonkwo, nke na-enye ohere nbelata ihe mgbu na mbufụt na nkwonkwo.
Compoundlọ a na-arụ ọrụ n'ime sel, na-egbochi ọrụ nke ụfọdụ enzymes, ndị JAK kinases, nke na-egbochi mmepụta nke ụfọdụ cytokines. Mgbochi a na-ebelata mmeghachi mkpali nke usoro ahụ ji alụso ọrịa ọgụ, si otú ahụ na-ebelata mbufụt nke nkwonkwo.
Ihe ngosi
A na-egosi Tofacitinib Citrate maka ọgwụgwọ nke ọrịa ogbu na nkwonkwo na-adịghị arụ ọrụ nke na-adịghị arụ ọrụ nke ọma, na ndị ọrịa toro eto na-azaghị ọgwụgwọ ndị ọzọ.
Esi ewere
I kwesiri iwere mbadamba 1 nke Tofacitinib Citrate 2 ugboro ubochi, nke enwere ike iwere ya ma obu ya na ogwu ndi ozo maka oria ogbu na nkwonkwo, dika methotrexate, dika ima atu.
A ga-eloda mkpụrụ osisi Tofacitinib Citrate dum, na-enweghị imebi ma ọ bụ ịta ata yana otu iko mmiri.
Mmetụta dị n'akụkụ
Offọdụ n'ime mmetụta ndị dị na Tofacitinib Citrate nwere ike ịgụnye ọrịa na imi na pharynx, oyi baa, herpes zoster, bronchitis, flu, sinusitis, ọrịa urinary tract, ọrịa pharynx, mgbanwe nchoputa ọbara na mmụba imeju na-arịwanye elu, uru bara ụba, mgbu afọ. , ọgbụgbọ, afọ mgbu, afọ ọsịsa, ọgbụgbọ, afọ iri nri, ụba abụba ọbara na mgbanwe cholesterol, mgbu akwara, akwara ma ọ bụ akwara, nkwonkwo mgbu, anaemia, ahụ ọkụ, oke ike ọgwụgwụ, ọzịza na nsọtụ nke ahụ, isi ọwụwa, nsogbu ụra ọbara mgbali elu, mkpụmkpụ nke ume, ụkwara ma ọ bụ hives na akpụkpọ ahụ.
Nkwekọrịta
A machibidoro Tofacitinib Citrate maka ụmụaka na ndị nọ n'afọ iri na ụma n'okpuru afọ 18, ndị ọrịa nwere ọrịa imeju siri ike yana maka ndị ọrịa nwere ihe nfụkasị na Tofacitinib Citrate ma ọ bụ ihe ndị ọzọ nke usoro ahụ.
Na mgbakwunye, ekwesighi iji ụmụ nwanyị dị ime ma ọ bụ ụmụ nwanyị na-enye ara ara na-enweghị ndụmọdụ dọkịta.